Trivitron’s new Neonatal IRT aims for better diagnosis of birth ailments
Aiming at creating a better future for newborn babies in the country by providing corrective diagnosis at birth, Trivitron healthcare has come up with a new test – Neonatal IRT which will be included in their existing newborn screening kit for India This test helps to detect disorders which may harm the newborn in later stages of life.
Trivitron healthcare, India’s largest medical technology company of Indian origin has always kept their focus on delivering cost-effective medical technology solutions and services to the underserved. Neonatal IRT can detect disorders affecting the lungs, pancreas, intestine and liver. With this test, the parents can start taking precautions in the early stages of life and prevent the child from life-long disorders. Majority of infants infected in utero are asymptomatic at birth, particularly if maternal infection occurs during third trimester, with sequel appearing later in life. If untreated during the early stages, problems will start appearing during their teens.
How the Neonatal IRT test works? A sample of blood is either taken from the bottom of the baby’s foot or a vein in the arm. A tiny drop of blood is collected onto a piece of filter paper and allowed to dry. The dried blood sample is sent to the lab for analysis. The blood sample is examined for increased levels of immunoreactive trypsinogen (IRT). This is a protein produced by the pancreas that is linked to Cystic fibrosis (CF), a recessive genetic disorder that can lead to serious complications and cause severe problems in the lungs, pancreas, liver, and intestine.
Immunoreactive Trypsinogen (IRT) is a pancreatic enzyme precursor found in the blood, and the concentration is elevated in babies with CF, since pancreatic ducts are partially blocked leading to abnormal enzyme drainage. This occurs even if infants are pancreatic sufficient. If the IRT is elevated in two tests then the infant will be referred for a sweat test.
Dr. GSK Velu, Founder and Managing Director of Trivitron Group of Companies said, “Trivitron Healthcare is taking strong steps towards women and child healthcare diagnosis. The thought behind adding two critical tests to the kit is to eradicate detected problems in the newborn at early stages for better lifestyle and to live a carefree life. Trivitron is known for its innovation in medical technology sector and making it available and affordable to larger section of the population across the globe”.